Who we are

Image Map

 

bioXclusters plus is the leading, European meta-cluster on personalised healthcare that brings together four of the most dynamic and fastest growing life science and healthcare clusters in Europe: Biocat (Catalonia), BioM (Bavaria), bioPmed (Piedmont) and Lyonbiopole (Auvergne-Rhône-Alps). Lyonbiopole is the cluster which coordinates the alliance. bioXclusters plus represents 3,300 SMEs which mainly operate in the areas of personalised medicine, oncology, cardiovascular, inflammatory, infectious diseases, and the central nervous system.

Read on to find out more about each of the meta-cluster’s innovative partners.

 

LyonbiopoleLyonbiopole, a French healthcare cluster fostering innovation in Auvergne-Rhône-Alpes, a vibrant territory in the heart of Europe. It is the cluster which coordinates bioXclusters plus.

Lyonbiopole is the gateway to healthcare innovation in Auvergne Rhône-Alpes Region. The cluster supports ambitious projects and companies in the health sector (including infectious diseases, cancer, nutrition, metabolic diseases). Its aim is to support innovative technologies, products and services for a more personalised medicine to the patient’s benefit.

The cluster’s missions are: 1) promoting the emergence of innovative R&D collaborative projects; 2) supporting SMEs for strategic partnerships, access to private investors, expertise and training; 3) fostering SME internationalisation and the cluster position at EU and an international level; 4) giving access to high-level, dedicated facilities. In 2015, Lyonbiopole represents a community of 190 members: 5 world-class leaders including Lyonbiopole’s founders (Sanofi Pasteur, bioMérieux, Merial, BD) – 17 research centres including 3 hospital university centres and almost 168 SMEs. Lyonbiopole received the European cluster excellence “Gold Label” from ECEI in 2014.

For more information, please contact Emilie Romeo at emilie.romeo@lyonbiopole.com or visit the webpage at www.lyonbiopole.com/en/lyonbiopole.

 
Biocat

Biocat coordinates and promotes the healthcare and life sciences sector in Catalonia. Its mission is to dynamise and support the public and private stakeholders that make up the BioRegion, Catalonia’s bioscience cluster, which encompasses companies, research groups and bodies, hospitals, universities, administrations and knowledge- and innovation-transfer support structures.

With a population of more than 7.5 million and a territory comparable to that of European countries like Finland, Belgium, the Netherlands and Israel, Catalonia has the most dynamic life sciences cluster in Spain and one of the most active in southern Europe. Biocat promotes initiatives to encourage research, innovation and business growth, with the aim of making this sector a driving force for the Catalan economy and boosting its global recognition.

The BioRegion of Catalonia is made up of 734 healthcare and life sciences companies and 89 research bodies, including 41 research centers, 15 university hospitals, 13 science and technology parks, 11 universities offering biosciences degrees, 7 technology centers and 2 large-scale facilities like the Alba-Cells Synchrotron and the Barcelona Supercomputing Center (BSC). The companies in the sector post yearly turnover of €14.36 billions, 7% of the GDP of Catalonia and employ 42,133 workers.

For more information, please contact Jordi Fàbrega at jfabrega@biocat.cat or visit the webpage at www.biocat.cat/en.

 
Einfaches RGB

BioM Biotech Cluster Development GmbH is the coordinating agency of the Bavarian Biotech Cluster for all fields of biotechnology. In addition, BioM coordinates the Munich Biotech Cluster with a focus on pharmaceutical biotechnology and personalised medicine. On behalf of the Bavarian Ministry of Economic Affairs, it serves as the one-stop-shop for biotechnology companies and start-ups in the region as well as the first point of contact for international business partners.

Bavaria is a constantly growing hotbed of innovation and ranks among the top biotech clusters in Europe – with more than 350 companies in the life science sector (biotech, pharma, CRO, suppliers – additionally another 1,000 companies belong to the sector of medical engineering), including 166 biotech SMEs and a well-filled drug development pipeline with more than 60 candidate drugs in clinical development and more than 80 candidates in the preclinic. BioM collaborates with other cluster organisations (e.g. medtech), life science incubators and research institutions in Bavaria, in order to connect the Bavarian life science hotspots within one large state-wide network.

BioM offers a wide range of services and events, including networking and partnering services for incoming global players interested in business contacts in Bavaria. It also manages a comprehensive information portal with an interactive company database and a large job market (www.bio-m.org). In a nation-wide competition in 2010, the Munich Biotech Cluster was awarded “Leading-Edge Cluster” status for the Munich research initiative “m4 – Personalized Medicine and Targeted Therapies”, also managed by BioM.

For more information, please contact Dr. Stephanie Wehnelt at wehnelt@bio-m.org or visit the webpage at www.bio-m.org/en.

 
Senza titolo-1bioPmed is the cluster for life sciences and human health for the Piedmont Region of Italy. Launched in 2009, bioPmed is now the result of the formal aggregation of about 70 players, ranging from large multinational corporations to hi-tech start-ups and innovative SMEs, and including universities and research foundations. They all work together and share a solid strategic plan to create innovation and development in the field of health.

“Creating a territorial innovation system in the field of life sciences and human health, internationally relevant and able to build value on a economic and social level and to improve quality of life for citizens”. This is the vision that will guide the development of bioPmed over the next five years.

Thanks to a community of over 350 companies, bioPmed is today the strongest regional health cluster in Italy, made up of firms, skills and motivated and open-minded people, who recognise the value of collaboration and use it as the core of their daily action. The 2016-2020 development plan envisages four strategic priorities: innovation, internationalisation, business development and positioning, each based on a series of targeted and specific services and activities, all geared to offer sectoral support to the regional players.

bioPmed is managed by Bioindustry Park Silvano Fumero SpA (www.bioindustrypark.eu), which in 2015 obtained the GOLD LABEL Certification of Excellence in Cluster Management from ESCA, the European Secretariat for Cluster Analysis: the only one awarded in Italy in the health sector and part of a restricted group of less than 10 throughout Europe.

For more information, please contact Alberto Baldi at baldi@bioindustrypark.it or visit the webpage at www.biopmed.eu

Advertisements

2 thoughts on “Who we are

  1. Pingback: Japan Mission Report: 60 European healthcare SMEs have participated in a very successful mission |

  2. Pingback: International expansion to Canada and America in healthcare: the bioXclusters session at BIOEurope Spring. |

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s